ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NATCOPHARM announcements Natco Pharma Limited announcements and dividends declared NSE

Natco Pharma Limited Complete list of announcements declared & dividend announcements by Natco Pharma Limited NATCOPHARM

Natco Pharma Limited NATCOPHARM listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Natco Pharma Limited NATCOPHARM

Board Meeting to discuss
Financial Results To consider and approve the Audited financial results for the period ended March 31, 2025
Announcement as on 13 May 2025

Company Announcement
Natco Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Announcement as on 17 April 2025

Company Announcement

Announcement as on 01 April 2025

Delhi HC asks Natco Pharma to pause Risdiplam launch amid patent dispute
The Delhi High Court has ordered Natco Pharma to maintain status quo on the launch of Risdiplam until April 2. Roche, which holds the patent for the drug, sought an injunction to prevent Natco from manufacturing it in India. The court highlighted the publi
Announcement as on 26 March 2025

Delhi HC rejects Roche's plea to block Natco Pharma on Risdiplam patent
The Delhi High Court denied Roche's request to temporarily restrain Natco Pharma from producing its spinal muscular atrophy drug, citing public interest and high prices. Natco is required to maintain detailed financial records and may owe damages if Roche
Announcement as on 24 March 2025

Announcements by Natco Pharma Limited first page | Next page | Prev page |

NATCOPHARM Natco Pharma Limited current price & indicator signals

Moving Averages for Natco Pharma Limited

  • 5Day Average: 965.63
  • 12Day Average: 939.03
  • 20Day Average: 912.41
  • 50Day Average: 1010.34
  • 100Day Average: 1001.84
  • 150Day Average: 961.67
  • 200Day Average: 929.42

NATCOPHARM Indicators & signals

Indicator MACD (12,26,9)

944.96, 946.62, -17.57
Indicator MACD is in negative zone

Indicator ADX (14)

16.79, 22.91, 16.32
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 46
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NATCOPHARM Natco Pharma Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
10 Fri Jul 2026 984.10 948.00 to 987.95 2.34% 0.89 times
09 Thu Jul 2026 961.60 956.25 to 989.50 -0.49% 0.55 times
08 Wed Jul 2026 966.30 957.60 to 997.30 -1.81% 1.34 times
07 Tue Jul 2026 984.15 924.00 to 988.80 5.6% 2.96 times
06 Mon Jul 2026 932.00 919.90 to 941.40 0.06% 0.35 times
03 Fri Jul 2026 931.40 927.55 to 939.10 -0.33% 0.27 times
02 Thu Jul 2026 934.50 922.05 to 939.80 0.9% 0.51 times
01 Wed Jul 2026 926.20 915.75 to 951.50 -0.55% 0.73 times
30 Tue Jun 2026 931.30 915.50 to 935.00 1.28% 0.8 times
29 Mon Jun 2026 919.50 890.30 to 924.00 1.75% 1.48 times
25 Thu Jun 2026 903.70 898.00 to 918.20 1.13% 1.02 times
24 Wed Jun 2026 893.60 888.00 to 913.60 0.08% 0.74 times

Videos related to: NATCOPHARM announcements Natco Pharma Limited announcements and dividends declared NSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NATCOPHARM announcements Natco Pharma Limited announcements and dividends declared NSE

 

Back to top